Vimarsana
Biggest News Aggregation in the World

Page 48 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

Feds Suspend Research Support at NYSPI - Vimarsana News

Feds Suspend Research Support at NYSPI

The federal Office for Human Research Protections has taken the unusual step of suspending all federally supported research at the New York State Psychiatric Institute, which is affiliated with Columbia University.

PetVivo Holdings, Inc. (NASDAQ:PETV) Q1 2024 Earnings Call Transcript - Vimarsana News

PetVivo Holdings, Inc. (NASDAQ:PETV) Q1 2024 Earnings Call Transcript

PetVivo Holdings, Inc. (NASDAQ:PETV) Q1 2024 Earnings Call Transcript August 11, 2023 Operator: All right. Welcome, everyone, to the PetVivo Holdings, Inc., 2024 Fiscal Year First Quarter Earnings Report. We will now hand over to John Dolan and take it from there. Thank you. John Dolan: Thank you, operator. Greetings, and welcome to the PetVivo […]

Source: yahoo.com
Inhaling Pleasant Scents Tied to a Dramatic Boost in Memory - Vimarsana News

Inhaling Pleasant Scents Tied to a Dramatic Boost in Memory

Individuals who breathed in a pleasant odor while sleeping experienced a dramatic improvement in memory compared with healthy controls, early research shows.

Scalp Cooling for Chemo Hair Loss Strikes Out With Patients - Vimarsana News

Scalp Cooling for Chemo Hair Loss Strikes Out With Patients

Investigators found no differences in perceived hair loss, quality of life, and other outcomes between women who opted for scalp cooling during breast cancer chemotherapy and those who did not.

Medical Treatment for Appendicitis Effective Long-Term - Vimarsana News

Medical Treatment for Appendicitis Effective Long-Term

More than 70% of patients who avoided appendectomy in two Swedish clinical trials had successful outcomes over two decades later.